Client Alerts & Insights
FTC Announces Changes to HSR Thresholds and Fees
January 30, 2023
Authored By:
On January 26, 2023, the Federal Trade Commission (“FTC”) published in the Federal Register changes in the reporting thresholds under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”). The FTC updates these thresholds annually based on changes in US gross national product. The new thresholds, shown below, will become effective on February 27, 2023.
|
Threshold |
2023 Adjustment |
|
Minimum Size-of-Transaction Test |
$111.4 million |
|
Size-of-Person Test |
$22.3 million and $222.7 million |
|
Size-of-Transaction above which Size-of-Person test no longer applies |
$445.5 million |
Additionally, on December 29, 2022, President Biden signed the Fee Modernization Act into law, which decreases the HSR filing fees for smaller transactions and increases the HSR filing fees for larger transactions. The below filing fees for all HSR filings will also become effective on February 27, 2023.
|
Size of Transaction |
Filing Fee |
|
Less than US $161.5 million |
$30,000 |
|
$161.5 million or greater, but less than $500 million |
$100,000 |
|
$500 million or greater, but less than $1 billion |
$250,000 |
|
$1 billion or greater, but less than $2 billion |
$400,000 |
|
$2 billion or greater, but less than $5 billion |
$800,000 |
|
$5 billion or greater |
$2,250,000 |
Even if a transaction is reportable based on these thresholds, it may qualify for an exemption. The above-listed thresholds will remain in effect until the next annual adjustment, expected in early 2024.
Should you have any questions about the new HSR thresholds, filing fees, or how to proceed with an HSR filing, please feel free to contact Connie Porter at cporter@beneschlaw.com or Logan Bryant at lbryant@beneschlaw.com.
Latest News
Medical First, Recreational Later? DOJ’s Cannabis Order and the Stakes Ahead
DOJ’s April 2026 order immediately moved FDA-approved and state-licensed medical cannabis to Schedule III, removing harsh tax penalties for medical operators, while leaving adult-use cannabis under stricter Schedule I controls pending further administrative review.
New Sentencing Guidelines for Economic Crimes Effective November 1, 2026
In March we reported on the U.S. Sentencing Commission’s proposed amendments to the Federal Sentencing Guidelines (the “Guidelines”). On April 16, 2026, the bipartisan United States Sentencing Commission (the “Commission”) voted unanimously to adopt that package of amendments, without modification.
Judicial Green Light: Court Upholds NLRB’s Cemex Decision
On April 21st, 2026, the U.S. Court of Appeals for the Ninth Circuit upheld the National Labor Relations Board’s (“NLRB”) decision in Cemex Construction Materials Pacific, LLC., reinforcing a significant shift in federal labor law governing union recognition and employer conduct during organizing campaigns.
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
The new LEAD Model, launching in 2027, is CMS’s next-generation value-based care framework for kidney care, integrating CKD and ESRD patients into standard ACOs with a 10-year benchmark period, new payment options and greater flexibility for nephrology-led organizations.